London, UK. 28 June 2011. A new report by visiongain, a London-based business information provider, predicts that the global lyophilisation market will be worth $3.25bn by 2015. The market generated $1.99bn in 2010, according to Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021, published in June 2011.
Lyophilisation, also known as freeze drying, is a well-established technique used in the pharmaceutical industry, as well as in other industries. In the pharmaceutical industry lyophilisation helps to stabilise labile/unstable products such as vaccines and biologics (biological drugs). This market has significant potential for growth with developments in freeze drying technology that will benefit the industry and its customers, extending performance and applications.
Visiongain's market industry analyst, says: "The market for lyophilisation has enjoyed strong growth in recent years, driven by new products and drug classes, especially in biotechnology. Over the course of the decade there will be greater demand for lyophilisation services, particularly those driven by the growing market for injectable therapeutics."
Visiongain's research suggests that the world lyophilisation market will benefit from the launch of new biologic drugs and vaccines. For biologic drugs, parenteral routes of administration will remain the most important. Lyophilisation is an established method in the formulation of biological products. There are under-met needs for improved stability and cost effectiveness, as well as for more convenience in transport, storage and use of therapeutic agents. Rapid stabilisation, long-term product stability, ease of reconstitution and process advantages for heat-sensitive products will drive growth of the lyophilisation technology and services market.
Visiongain predicts that this market will grow steadily to 2021. The future of the lyophilisation industry and market appears promising, with increasing demand in many therapeutic areas. This new study complements visiongain's wide range of analytical reports in healthcare and other industry areas.
For further information about this study please visit http://www.visiongain.com/Report/633/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021
Email: Contact Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 207 336 6100
ENDS
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100
About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Metals, Energy, Telecoms, Pharmaceutical, Defence and Materials sectors.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Pharmaceutical, Telecoms, Energy, Defence and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.